Meeting
Abstract Number: 214
SHM Converge 2021
Background: Healthcare costs in the United States continue to increase, largely driven by the high cost of pharmaceuticals. Cost transparency, the act of showing the cost of drugs to providers, has been proposed as a method of reducing healthcare costs, but its effectiveness has not been studied on a large scale. Methods: We tracked the […]
Abstract Number: 457
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Providers are often frustrated by the lack of cost transparency in the US healthcare system. Studies aimed at assessing providers’ knowledge of medical costs generally show poor cost awareness. Pilot studies examining the effects of price transparency initiatives on healthcare utilization have explored a wide variety of formats, and have returned mixed results. Methods: […]